Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
754
-
Total 13F shares, excl. options
-
236M
-
Shares change
-
-643K
-
Total reported value, excl. options
-
$32.7B
-
Value change
-
-$91.8M
-
Put/Call ratio
-
1.13
-
Number of buys
-
325
-
Number of sells
-
-354
-
Price
-
$138.99
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2016
844 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q1 2016.
Elevance Health, Inc. - Common Stock (ELV) has 754 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 236M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (24.6M shares), VANGUARD GROUP INC (15.6M shares), STATE STREET CORP (10.4M shares), FMR LLC (8.26M shares), BlackRock Institutional Trust Company, N.A. (7.4M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (7.27M shares), BAILLIE GIFFORD & CO (5.41M shares), Viking Global Investors LP (4.85M shares), NORDEA INVESTMENT MANAGEMENT AB (4.78M shares), and WELLINGTON MANAGEMENT GROUP LLP (4.08M shares).
This table shows the top 754 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.